ARMEN GARO H 4
4 · AGENUS INC · Filed Feb 24, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) CEO Garo H. Armen Receives Stock Award
What Happened
Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), received 4,829 shares on February 20, 2026 as stock-based salary payment (reported as an award/acquisition). The shares were valued at the closing price of $3.06 on that date, for an aggregate value of approximately $14,777. These shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.
Key Details
- Transaction date and price: 2026-02-20 at $3.06 per share (closing price).
- Shares issued: 4,829; total value reported: $14,777 (net amount of Dr. Armen’s salary for the pay period ending Feb 20, 2026).
- Vesting: Shares are fully vested on the date of issuance.
- Holdings after transaction: The Form 4 does not state Dr. Armen’s total beneficial ownership after this issuance. Related disclosures note 23,950 shares held by the Garo Armen 2020 2 Year AG GRAT and 5,000 shares owned by Pixie Partners (a partnership where Dr. Armen is a general partner; he disclaims beneficial ownership to the extent of his pecuniary interest). The newly issued shares are held in Dr. Armen’s IRA accounts.
- Filing timeliness: Report filed 2026-02-24 for the 2026-02-20 transaction (filed within the standard reporting window).
Context
This transaction reflects salary paid in company stock at the executive’s request and approved by the Compensation Committee, not an open-market purchase or sale. Compensation-issued shares are routine and reflect remuneration arrangements rather than a direct buy/sell signal about insider sentiment.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-02-20$3.06/sh+4,829$14,777→ 325,541 total
- 31,298(indirect: See Footnote)
Common Stock
[F3] - 28,950(indirect: See Footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending February 20, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- [F2]$3.06 is the closing price of our Common Stock on February 20, 2026, the last trading day for the payroll date for the pay period ending February 20, 2026.
- [F3]Shares are held in Dr. Armen's IRA accounts.
- [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.